These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 9149033)
1. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line. Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033 [TBL] [Abstract][Full Text] [Related]
2. Biological aspects of neuroblastomas identified by mass screening in Quebec. Brodeur GM; Look AT; Shimada H; Hamilton VM; Maris JM; Hann HW; Leclerc JM; Bernstein M; Brisson LC; Brossard J; Lemieux B; Tuchman M; Woods WG Med Pediatr Oncol; 2001 Jan; 36(1):157-9. PubMed ID: 11464873 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896 [TBL] [Abstract][Full Text] [Related]
4. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line. Valent A; Venuat AM; Danglot G; Da Silva J; Duarte N; Bernheim A; Bénard J Med Pediatr Oncol; 2001 Jan; 36(1):100-3. PubMed ID: 11464856 [TBL] [Abstract][Full Text] [Related]
6. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909 [TBL] [Abstract][Full Text] [Related]
7. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780 [TBL] [Abstract][Full Text] [Related]
8. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas. Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371 [TBL] [Abstract][Full Text] [Related]
9. Biology of neuroblastomas in Japan found by screening. Hayashi Y; Hanada R; Yamamoto K Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):342-7. PubMed ID: 1456401 [TBL] [Abstract][Full Text] [Related]
10. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis]. Chassevent A; Bénard J Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866 [TBL] [Abstract][Full Text] [Related]
11. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Pietsch T; Göttert E; Meese E; Blin N; Feickert HJ; Riehm H; Kovacs G Anticancer Res; 1988; 8(6):1329-33. PubMed ID: 3218965 [TBL] [Abstract][Full Text] [Related]
13. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855 [TBL] [Abstract][Full Text] [Related]
15. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice. Sleight BJ; Soukup S; Ballard ET; Parysek LM Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111 [TBL] [Abstract][Full Text] [Related]
16. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528 [TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963 [TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project. Woods WG; Lemieux B; Tuchman M Pediatrics; 1992 Jan; 89(1):114-8. PubMed ID: 1727993 [TBL] [Abstract][Full Text] [Related]
19. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Mora J; Cheung NK; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald WL Cancer Res; 2001 Sep; 61(18):6892-8. PubMed ID: 11559566 [TBL] [Abstract][Full Text] [Related]